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LETTERS TO 
FLUOXETINE INDUCED AKATHISIA AND 
SUICIDALLY 
Sir, 
Dr. S. Haque Nizamie & P.N. Suresh 
Kumar in their article 'fluoxetine induced 
extrapyramidal symptoms: Case reports' in 
Indian Journal of Psychiatry 1998, Vol. 1,No. 1, 
87-89 have categorically remarked absence of 
suicidal ideation in both the cases who had 
developed pseudoparkinsonism and akathisia 
while being treated with fluoxetine alone and in 
combination with heloperidol & lithium. Akathisia 
had appeared in these cases on 5th day in easel 
and 6th & 14th day in case 2 respectively. The 
absence of suicidal ideation has been attributed 
to early detection and treatment of akathisia. 
The development of akathisia and emergence/ 
aggravation of suicidality is a complex issue. 
Suicidal ideation has been observed with anti 
depressant pharmacotherapy and has not been 
proved to be associated with any specific type 
of antidepressant. Whether certain anti 
depressants precipitate and or aggravate suicidal 
ideation in a subgroup of patients, responder as 
well as non responder to therapy is uncertain. It 
is unrelated to the dosage of fluoxetine (Mann & 
Kapur,1991). Suicidal ideation has been 
observed appearing suddenly, concurrent with 
neuroleptic induced akathisia and disappeared 
when akathisia was treated (Drake & Ehrlich, 
1985). Fluoxetine induced akathisia is 
indistinguishable from that of neuroleptic induced 
akathisia (Lipinski et al., 1989). The proposed 
link between f'uoxetine induced akathisia and 
suicidality is explained on the basis of four 
neuron model of extrapyramidal motor system, 
in which increased serotonin activity by inhibiting 
the nigrostriatal dopamine tract, is capable of 
inducing a syndrome named Extra Pyramidal 
Dysphoric Reactions, one extreme form of 
manifestation of which is suicidal ideation 
(Hamilton & Opler,1992). I would like to raise a 
question and request for comments from the 
author on severity of akathisia and its relation to 
suicidality, which is lacking in the present case 
reports. Suicidality may be related to severity of 
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akathisia rather than its duration. 
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RISPERIDONE IN INDIAN PATIENTS WITH 
SCHIZOPHRENIA 
Sir, 
We read with intrest the study by 
Agarwal etal.(1998) titled 'Risperidone in Indian 
patients with Schizophrenia'. Limitations of an 
open-label study not withstanding, this study has 
a few shortcomings which we would like to 
mention. 
First, the patients entering the study 
were rated on Positive and Negative Symptom 
Scale (PANSS) after a week's wash-out period. 
A more meaningful approach would have been 
to rate the patients at first contact while they 
were still on medication and then a week after 
wash-out. This enables an investigator to know 
whether withdrawal from neuroleptics contributed 
to any improvement in symptomatology. It is 
known that many patients under routine clinical 
treatment actually benefit from a reduction in 
their medication dose rather than an increase 
(Johnson & Johnson,1995). This may be 
particularly true in patients with extrapyramidal 
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